Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration. [PDF]
Basak B +3 more
europepmc +1 more source
Metabolic Malfunction Mars Muscle Mitochondria
Guido Primiano, Ian Holt
openaire +2 more sources
Metrnl: A Novel Therapeutic Target in Atherosclerosis
ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley +1 more source
The Role of Autophagy in the Pathogenesis of Mitochondrial Diseases. [PDF]
Avdonina ED, Kutsev SI, Shestopalov AV.
europepmc +1 more source
ATP Citrate Lyase in Metabolic Disease: Mechanistic Insights and Clinical Potential
ATP citrate lyase (ACLY) is a central metabolic hub that diverts mitochondrial citrate to fuel de novo lipogenesis, cholesterol biosynthesis, and protein acetylation. Given its robust correlation with pathological changes in multiple human diseases, ACLY inhibitors featuring distinct pharmacological strengths have been developed for therapeutic ...
Wenbiao Wang +5 more
wiley +1 more source
CaMKIIγ/δ contributes to mitochondrial metabolic adaptation in skeletal muscle during endurance training. [PDF]
Tsukahara R +8 more
europepmc +1 more source
Macrophage‐derived S100 calcium‐binding protein A9 (S100A9) promotes the pathological progression of pulmonary arterial hypertension (PAH). S100A9 upregulates the interaction between signal‐transducing adaptor protein 2 and leucine‐rich repeat kinase 2, thereby regulating mitochondria–endoplasmic reticulum (ER) contact.
Chen Gong +15 more
wiley +1 more source
Mitochondrial Ca<sup>2+</sup> Influx via MCU-1 Contributes to Oxidative Mitochondrial Defects in PDR-1/Parkin-Deficient <i>Caenorhabditis elegans</i> Body-Wall Muscle. [PDF]
Kawasumi M, Teranishi M.
europepmc +1 more source
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura +11 more
wiley +1 more source
An Ultrastructural and Proteomic Analysis in DM1 Young Adults' Myoblasts: Stressed RER and Mitochondrial Dysfunction Involvement. [PDF]
Del Carratore R +8 more
europepmc +1 more source

